$2.68
0.124.69%
At close: Aug 24, 5:00 PM EST
$2.62
0.062.34%
Pre-Market: 4:00 AM EST
Dogwood Therapeutics (DWTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.14 | $-0.20 | $-1.00 | $-1.44 |
| Actual | $-0.34 | $-0.15 | $-0.26 | $-8.20 |
| Surprise | -142.9% | +25.0% | +74.0% | -469.4% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.15 | $-0.16 | $-0.16 | $-0.16 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $-0.34 | $-0.14 | -142.9 % |
| Q1 | May 14, 2026 | $-0.15 | $-0.20 | 25.0 % |
| Q4 | Mar 18, 2026 | $-0.26 | $-1.00 | 74.0 % |
| Q3 | Nov 6, 2025 | $-8.20 | $-1.44 | -469.4 % |